辉瑞在三季报将全年收入指引再调高15亿美元,首席执行官特别点名新冠口服药的贡献。当地时间10月29日,美国辉瑞((NYSE: PFE)公布2024年三季报,第三季度营收177.02亿美元,同比增长31%,高于市场预估150.8亿美元。不考虑新冠产品的影响,收入同比增长14%。第三季度调整后利润60.5亿美元,调整后每股收益1.06美元,去年同期为每股亏损0.17美元。前三季度整体来看,收入...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.